LSPCX
Price
$5.61
Change
+$0.01 (+0.18%)
Updated
Sep 17 closing price
Net Assets
73.79M
MBXCX
Price
$38.32
Change
-$0.04 (-0.10%)
Updated
Sep 17 closing price
Net Assets
8.34B
Interact to see
Advertisement

LSPCX vs MBXCX

Header iconLSPCX vs MBXCX Comparison
Open Charts LSPCX vs MBXCXBanner chart's image
LoCorr Spectrum Income C
Price$5.61
Change+$0.01 (+0.18%)
VolumeN/A
Net Assets73.79M
Catalyst/Millburn Hedge Strategy C
Price$38.32
Change-$0.04 (-0.10%)
VolumeN/A
Net Assets8.34B
LSPCX vs MBXCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LSPCX vs. MBXCX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSPCX is a Hold and MBXCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXCX has more cash in the bank: 8.34B vs. LSPCX (73.8M). LSPCX pays higher dividends than MBXCX: LSPCX (7.42) vs MBXCX (0.93). LSPCX was incepted earlier than MBXCX: LSPCX (12 years) vs MBXCX (10 years). LSPCX (4.64) is less costly to investors than MBXCX (3.03). LSPCX is a more actively managed with annual turnover of: 57.00 vs. MBXCX (48.00). LSPCX (2500) and MBXCX (2500) have matching initial minimum investment requirements. MBXCX annual gain was more profitable for investors over the last year : 5.92 vs. LSPCX (5.11). LSPCX return over 5 years is better than : 49.35 vs. MBXCX (45.71).
LSPCXMBXCXLSPCX / MBXCX
Total Expense Ratio4.613.03152%
Annual Report Gross Expense Ratio4.643.03153%
Fund Existence12 years10 years-
Gain YTD7.6132.266336%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets73.8M8.34B1%
Annual Yield % from dividends7.420.93801%
Returns for 1 year5.115.9286%
Returns for 3 years8.5610.3483%
Returns for 5 years49.3545.71108%
Returns for 10 years33.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRCPX24.59N/A
N/A
Nuveen Large Cap Value Premier
UGMVX12.23N/A
N/A
Victory Global Managed Volatility
LHCSX19.36N/A
N/A
Lord Abbett Health Care R4
GSMAX21.03N/A
N/A
Goldman Sachs Small/Mid Cap Growth A
SCJIX8.25N/A
N/A
Steward Covered Call Income I